The FY2025 (Dec) proxy of Cardiff Oncology names 20 peer companies for pay. Pay versus performance data of Cardiff Oncology for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Corvus Pharmaceuticals | ||
| Compass Therapeutics | ||
| ALX Oncology Holdings, Inc. | Not disclosed | Not disclosed |
| Acrivon Therapeutics, Inc. | Not disclosed | Not disclosed |
| Actinium Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| BioAtla, Inc. | Not disclosed | Not disclosed |
| Black Diamond Therapeutics, Inc. | Not disclosed | Not disclosed |
| Candel Therapeutics | Not disclosed | Not disclosed |
| Curis, Inc. | Not disclosed | Not disclosed |
| Elevation Oncology, Inc. | Not disclosed | Not disclosed |
| Immix Biopharma, Inc. | Not disclosed | Not disclosed |
| Kezar Life Sciences, Inc. | Not disclosed | Not disclosed |
| Kronos Bio, Inc. | Not disclosed | Not disclosed |
| Lantern Pharma, Inc. | Not disclosed | Not disclosed |
| Leap Therapeutics, Inc. | Not disclosed | Not disclosed |
| Pyxis Oncology, Inc. | Not disclosed | Not disclosed |
| Syros Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Tempest Therapeutics, Inc. | Not disclosed | Not disclosed |
| Viracta Therapeutics, Inc. | Not disclosed | Not disclosed |
| Werewolf Therapeutics, Inc. | Not disclosed | Not disclosed |
20 companies
Changes by year
FY2025 (Dec) proxy
- AddedAcrivon Therapeutics, Inc.pay peer group
- AddedBlack Diamond Therapeutics, Inc.pay peer group
- AddedCompass Therapeuticspay peer group
- AddedImmix Biopharma, Inc.pay peer group
- AddedLantern Pharma, Inc.pay peer group
- AddedLeap Therapeutics, Inc.pay peer group
- AddedPyxis Oncology, Inc.pay peer group
- AddedSyros Pharmaceuticals, Inc.pay peer group
- AddedTempest Therapeutics, Inc.pay peer group
- RemovedBolt Biotherapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedCyteir Therapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedGenprex, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedHarpoon Therapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedMEI Pharma, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedMustang Bio, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedOlema Pharmaceuticalspay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedOncternal Therapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedRain Oncology, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
FY2024 (Dec) proxy
- AddedALX Oncology Holdings, Inc.pay peer group
- AddedBolt Biotherapeutics, Inc.pay peer group
- AddedCandel Therapeuticspay peer group
- AddedCorvus Pharmaceuticalspay peer group
- AddedCyteir Therapeutics, Inc.pay peer group
- AddedElevation Oncology, Inc.pay peer group
- AddedKronos Bio, Inc.pay peer group
- AddedRain Oncology, Inc.pay peer group
- AddedViracta Therapeutics, Inc.pay peer group
- AddedWerewolf Therapeutics, Inc.pay peer group
- RemovedAldeyra Therapeuticspay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedAmpio Pharmaceuticals, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedCalithera Biosciences, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedCymaBay Therapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedFrequency Therapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedInfinity Pharmaceuticals, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedSurface Oncology, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedTCR2 Therapeutics, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedTRACON Pharmaceuticals, Inc.pay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedViking Therapeuticspay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedXOMA Corporationpay peer groupdue to misalignment with the peer selection criteria or due to acquisition
FY2023 (Dec) proxy
- AddedBioAtlapay peer group
- AddedGenprexpay peer group
- AddedHarpoon Therapeuticspay peer group
- AddedOlema Pharmaceuticalspay peer group
- AddedSurface Oncologypay peer group
- AddedTRACON Pharmaceuticalspay peer group
- RemovedAnaptysbiopay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedCTI BioPharmapay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedCogent Biosciencespay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedCrinetics Pharmaceuticalspay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedSierra Oncoloypay peer groupdue to misalignment with the peer selection criteria or due to acquisition
- RemovedSyndax Pharmaceuticalspay peer groupdue to misalignment with the peer selection criteria or due to acquisition
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.